US 12220420
Combination therapy for cancer treatment
granted A61KA61K31/198A61K31/4196
Quick answer
US patent 12220420 (Combination therapy for cancer treatment) held by Galera Labs, LLC expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Galera Labs, LLC
- Grant date
- Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/198, A61K31/4196, A61K31/555, A61K31/635